Optimizing prophylactic antibiotic regimen in patients admitted for transrectal ultrasound-guided prostate biopsies: A prospective randomized study.
BACKGROUND
Transrectal ultrasound-guided prostate biopsies (TRUSBx), in spite of being one of the most frequently performed urological office procedures, are associated with a spectrum of complications, most significantly including infection. The aim of the study is to evaluate the prevalence of fluoroquinolone-resistant bacteria in rectal swabs from our local population prior to TRUSBx and to identify risk factors among a patient population harboring fluoroquinolone-resistant organisms.


METHODS
We prospectively included 541 men who were submitted for TRUSBx in our center from March 2011 to June 2015. The indications for TRUSBx were an elevated prostate-specific antigen level and/or abnormal digital rectal exam. All patients were randomly divided into two groups: Group 1 (n = 279 cases) who received standard empirical prophylactic antibiotics and Group 2 who received targeted prophylaxis based on a rectal swab culture and susceptibility result. Differences in risk factors between quinolone-resistant and nonresistant patients were compared. Univariate and multivariate analyses were performed to identify independent potential risk factors associated with fluoroquinolone-resistant rectal flora.


RESULTS
Sixteen out of 271 men developed infectious complications after TRUSBx in the group receiving standard empirical prophylaxis (5.7%). No men in the group who received targeted prophylactic antibiotic guided by rectal swab developed infectious complications. Among the 262 patients who underwent prebiopsy rectal swab cultures, 76 men (29%) displayed fluoroquinolone-resistant rectal flora (29%). In the multivariate analysis, a history of antibiotic exposure before prostate biopsy was the only independent factor associated with an increased risk of fluoroquinolone resistance.


CONCLUSIONS
Determining the prevalence of fluoroquinolone resistance in rectal flora has important implications in the selection of targeted prophylactic antibiotic regimens. Antimicrobial profiles guided by rectal swabs may prove useful to optimize prophylaxis prior to TRUSBx; this strategy is effective at reducing the rates of infectious complications, including sepsis, especially in men at higher risk of infectious complications.
Urology Department, Alexandria University, Alexandria, Egypt.
Ahmed
A
Fahmy
Urology Department, Alexandria University, Alexandria, Egypt.
Hazem
H
Rhashad
Urology Department, Alexandria University, Alexandria, Egypt.
Mohamed
M
Mohi
Urology Department, Alexandria University, Alexandria, Egypt.
Ahmed
A
Elabbadie
Urology Department, Alexandria University, Alexandria, Egypt.
Ahmed
A
Kotb
Biopsy; Prophylactic antibiotic; Prostate biopsy; Transrectal
J Urol. 2011 Apr;185(4):1283-8
21334021
Eur Radiol. 2006 Apr;16(4):939-43
16391904
Urology. 1998 Oct;52(4):552-8
9763070
Urol Int. 2010;84(4):395-9
20224265
BJU Int. 2011 Aug;108(3):305-6
21771239
BJU Int. 2011 Oct;108(8):1233-4
21958223
BJU Int. 2010 Oct;106(7):1017-20
20346055
Urology. 2011 Aug;78(2):250-5
21705048
J Urol. 2012 Apr;187(4):1275-9
22341272
Int J Urol. 2014 Feb;21(2):152-5
23906113
J Urol. 2013 Mar;189(3):911-5
23009873
Am J Infect Control. 2005 Aug;33(6):326-32
16061138
Br J Urol. 1996 Jun;77(6):851-5
8705220
Urol Int. 2010;85(2):147-51
20453481
Urology. 2011 May;77(5):1035-41
21420152
Eur Urol. 2012 Jun;61(6):1110-4
22244150
BJU Int. 2000 Apr;85(6):682-5
10759665
BJU Int. 2011 Mar;107(5):760-4
21029317
J Urol. 2013 Feb;189(2):535-40
22982426
J Urol. 2010 Mar;183(3):963-8
20089283
J Urol. 2011 Nov;186(5):1830-4
21944136
Clin Infect Dis. 2013 Jul;57(2):267-74
23532481
J Urol. 2013 Apr;189(4):1326-31
23041343
Clin Infect Dis. 2001 Apr 15;32(8):1162-71
11283805
Urology. 2012 Mar;79(3):556-61
22386395